MiNK Therapeutics Files 8-K on Financials
Ticker: INKT · Form: 8-K · Filed: May 15, 2025 · CIK: 1840229
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
MiNK Therapeutics filed an 8-K on May 15, 2025, for financial reporting.
AI Summary
MiNK Therapeutics, Inc. filed an 8-K on May 15, 2025, reporting on its Results of Operations and Financial Condition, and including Financial Statements and Exhibits. The filing does not contain specific financial figures or operational updates within the provided text, but indicates a formal reporting event.
Why It Matters
This filing serves as a formal notification to investors and the public regarding the company's financial status and operational results, which can influence investment decisions.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of financial information and does not inherently present new risks.
Key Players & Entities
- MiNK Therapeutics, Inc. (company) — Registrant
- AgenTus Therapeutics, Inc. (company) — Former company name
- May 15, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition of MiNK Therapeutics, Inc., and to include Financial Statements and Exhibits.
What is the exact date of the report?
The exact date of the report is May 15, 2025.
What was MiNK Therapeutics, Inc.'s former company name?
MiNK Therapeutics, Inc.'s former company name was AgenTus Therapeutics, Inc.
In which state was MiNK Therapeutics, Inc. incorporated?
MiNK Therapeutics, Inc. was incorporated in Delaware.
What is the SEC file number for MiNK Therapeutics, Inc.?
The SEC file number for MiNK Therapeutics, Inc. is 001-40908.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 15, 2025 regarding MiNK Therapeutics, Inc. (INKT).